Navigation Links
Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium
Date:2/23/2011

Registrants to the largest European clinical and research bone meeting - the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) from March 23-26, 2011 - will receive free registration to the 1st IOF-ESCEO Pre-Clinical Symposium from March 22-23.

The IOF-ESCEO Pre-Clinical Symposium showcases new research at the cutting edge of basic and translational bone science. It will feature:

  • Eight plenary lectures by speakers E. Wagner, J.-P. David, A. Teti, Ph. Clzardin, M. Kassem, P. Bianco, T. Schinke and G. Karsenty
  • Meet-the-Faculty sessions: How to write a grant, C. Cooper; How to write a manuscript, G. Karsenty; How to build up a lecture, E. Wagner; Women in academic careers, A. Teti
  • Twenty-eight selected oral presentations (7 hours!).

Here's a sneak preview of 10 of the 28 orals and speakers:

  • DLK1/FA1 regulates the early chondrogenesis during embryonic endochondral bone formation process and its expression is modulated by TGF-β1 signaling pathway - B. Abdallah

  • Genetic variation in the LRP4 gene influences bone mineral density and hip geometry while missense mutations cause sclerosteosis - E. Piters

  • Sclerostin antibody treatment enhances fracture healing and increases bone mass and strength in non-fractured bones in an adult rat closed femoral fracture model - H. Ke

  • Genome wide association study identifies seven loci that account for 86% of the population attributable risk of paget's disease of bone - O. Albagha

  • Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor - J. Tuckermann

  • MicroRNA-138 targets focal adhesion kinase and regulates In Vivo - M. Kassem

  • Control of bone resorption by semaphorin 4D is dependent on ovarian function - I. Machuca-Gayet

  • Iron overload stimulates osteoclast differentiation of murine osteoclast progenitor RAW 264.7 Through the production of reactive oxygen species - J. Peng

  • MHC class II transactivator: a novel regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity - S. Cenci

  • Strontium ranelate inhibits key factors affecting bone remodelling in human osteoarthritic subchondral bone osteoblasts - J. Martel-Pelletier

Visit http://www.ecceo11-iof.org/pre-clinical-symposium for the complete list of 28 oral presentations and 8 plenary lectures.

We look forward to seeing you in Valencia! www.ecceo11-iof.org


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations
2. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
3. Symposium to provide forum for best pre-clinical and translational bone research
4. A missing enzyme conveys major heart protection in pre-clinical work
5. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
6. AAAS Symposium: New research facilitates scientific knowledge transfer
7. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
8. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
9. Oil spill symposium to convene scientists, media, policymakers and community leaders
10. Graduate physics students wins top honors in superconductivity symposium
11. Symposium marks milestones in honey bee management, research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or ... China, today announced its financial results for the fourth quarter ... 2016 Financial Highlights Total sales in ... terms, or increased by 13.6% in USD terms to $77.6 ... Gross profit increased by 13.3% to $46.8 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
Breaking Biology Technology: